drugset / Trial / NCT00567957

Remifentanil for General Anesthesia in Preeclamptics

NCT00567957 ↗

Phase 4 Unknown 50 enrolled Istanbul University
RandomizedParallel-groupQuadruple-blind

Summary

The purpose of this study is to determine whether remifentanil use in preeclamptic patients may blunt hemodynamic response to intubation during general anesthesia for cesarean section.

Timeline

Start
2008-02
Primary completion
—
Completion
2009-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Remifentanil Small molecule 0.5 ug/kg Intravenous

Indications